Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-17
2007-04-17
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S336000, C514S337000, C514S338000, C514S343000, C514S357000, C544S360000, C546S276400, C546S280400, C546S281100, C546S283400, C546S283700, C546S284100, C546S333000
Reexamination Certificate
active
10622320
ABSTRACT:
The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
REFERENCES:
patent: 5716955 (1998-02-01), Adams et al.
patent: 5716972 (1998-02-01), Adams et al.
patent: 5717100 (1998-02-01), Selnick et al.
patent: 6632945 (2003-10-01), Salituro et al.
patent: WO 95/02591 (1995-01-01), None
patent: WO 95/31451 (1995-11-01), None
patent: WO 96/21654 (1996-07-01), None
patent: WO 97/12876 (1997-04-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 97/47618 (1997-12-01), None
patent: WO 97/49689 (1997-12-01), None
patent: WO 98/02430 (1998-01-01), None
patent: WO 98/06715 (1998-02-01), None
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Douglas, Jr. Introduction to Viral Diseases, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1747, 1996.
Timothy F. Gallagher, et al., “Regulation of Stress-Induced Cytokine Production by Pyridinylimidazoles; Inhibition of CSBP Kinase,”Bioorganic&Medicinal Chemistry, 5(1), pp. 49-64, (1997).
Alison M. Badger, et al., “Pharmacological Profile of SB 203580, a Selective Inhibitor of Cytokine Suppressive Binding Protein/p38 Kinase, in Animal Models of Arthritis, Bone Resorption, Endotoxin Shock and Immune Function,”Journal of Pharmacology and Experimental Therapeutics, 279(3), pp. 1453-1461, (1996).
Timothy F. Gallagher, et al., “2,4,5- Triarylimidazole Inhibitors of IL-1 Biosynthesis,”Bioorganic&Medicinal Chemistry Letters, 5 (11), pp. 1171-1176, (1995).
Robert B. Layzer, “Degenerative Diseases of the Nervous System,” Cecile Textbook of Medicine, 20th Edition, vol. 1 pp. 1004-1010 (1996).
Joseph V. Simone, “Oncology: Introduction,” Cecile Textbook of Medicine, 20th Edition, vol. 1 pp. 2050-2057 (1996).
Bemis Guy W
Cochran John E
Duffy John P
Galullo Vincent P
Harrington Edmund M
Fish & Neave IP Group Ropes & Gray LLP
Haley Jr. James F.
Rao Deepak
Roise David A.
Vertex Pharmaceuticals Incorporated
LandOfFree
Inhibitors of p38 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of p38, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of p38 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3743709